Filed by the Registrant [X] | ||
Filed by a Party other than the Registrant [ ] | ||
Check the appropriate box: | ||
[ ] | Preliminary Proxy Statement | |
[ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | |
[ ] | Definitive Proxy Statement | |
[X] | Definitive Additional Materials | |
[ ] | Soliciting Material Pursuant to §240.14a-12 |
HSBC PORTFOLIOS | ||
(Name of Registrant as Specified In Its Charter) | ||
(Name
of Person(s) Filing Proxy Statement, if other than the
Registrant) |
Payment of Filing Fee (Check the appropriate box): | ||||
[X] | No fee required. | |||
[
] |
Fee computed on
table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | |||
1) | Title of each class of securities to which transaction applies: | |||
2) | Aggregate number of securities to which transaction applies: | |||
3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | |||
4) | Proposed maximum aggregate value of transaction: | |||
5) | Total fee paid: | |||
[
] |
Fee paid previously
with preliminary materials. | |||
[
] |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for
which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing. | |||
1) | Amount Previously Paid: | |||
2) | Form, Schedule or Registration Statement No.: | |||
3) | Filing Party: | |||
4) | Date Filed: | |||
![]() | ||
HSBC Funds | ||
HSBC Opportunity Fund | Aggressive Strategy Fund | |
HSBC Prime Money Market Fund | Balanced Strategy Fund | |
HSBC U.S. Treasury Money Market Fund | Moderate Strategy Fund | |
HSBC Emerging Markets Debt Fund | Conservative Strategy Fund | |
HSBC Emerging Markets Local Debt Fund | Income Strategy Fund |
HSBC Advisor Funds Trust
HSBC Opportunity Fund
April 14, 2016
To our Shareholders:
We need your vote.
We have been trying to reach you regarding your investment(s) in the above-named fund(s). We are asking for your immediate attention and response to an important shareholder matter. The Special Meeting of Shareholders, which was originally scheduled to take place on April 14, 2016, has been adjourned until April 29, 2016, 10:00 AM Eastern time, due to insufficient voting response from shareholders. Our records indicate that we have not yet received YOUR vote.
Shareholders are being asked to vote on the following proposals:
Proposals |
Shareholders Solicited to Vote | |||
1. | To approve election of five nominees to serve as Trustees on the Boards of Trustees (Proposal 1) |
All Funds | ||
2. | To approve the reorganization of each Trust into a single newly established Delaware statutory trust from a Massachusetts business trust or New York trust, as applicable (Proposal 2) |
All Funds | ||
3. | To approve an amendment to the current managers of managers arrangement for the Funds (Proposal 3) |
Certain Funds. Please see proxy statement at www.okapivote.com/HSBC for further details | ||
4. | To approve revisions to the Funds fundamental investment policies in order to conform and modernize the policies (Proposal 4) |
Certain Funds. Please see proxy statement at www.okapivote.com/HSBC for further details. |
As of April 14, 2016, a majority of the votes received have been cast in favor of the above proposals, not enough shares have voted to constitute a simple quorum for the meeting. Therefore, the proposals have not yet been approved.
Every account, no matter the size, has a direct impact on the outcome of the proxy vote.
Your Funds Board of Trustees unanimously recommends that you vote FOR the proposals.
No matter when you receive this email - even if it is past the indicated deadline, it is very important that you vote TODAY. Failure to vote could further delay the meeting and generate unnecessary additional costs.
If you have any questions, please call the Funds proxy solicitor, Okapi Partners, toll-free at 877-279-2311.
Thank you for your continued support.